1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Agendia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes anthracycline-based, docetaxel and capecitabine, tamoxifen - Breast Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 6600 | 2007-02-01 | 2022-11-17 |
Breast Neoplasms (1) · Carcinoma, Ductal, Breast (1) · Carcinoma, Lobular (1)
Capecitabine (1) · Docetaxel (1) · Letrozole (1) · Tamoxifen (1)
Netherlands (1)
Emiel Rutgers, MD, PhD (1) · Fatima Cardoso, MD (1) · Martine Piccart-Gebhart, MD, PhD (1)
PMID 22051734, PMID 24667714, PMID 27557300, PMID 32083990, PMID 33721561, PMID 38241603
2005 (1)